Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 196 entries
Sorted by: Best Match Show Resources per page
Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.

JAMA oncology

Landgren O, Hofmann JN, McShane CM, Santo L, Hultcrantz M, Korde N, Mailankody S, Kazandjian D, Murata K, Thoren K, Ramanathan L, Dogan A, Rustad E, Lu SX, Akhlaghi T, Kristinsson SY, Björkholm M, Devlin S, Purdue MP, Pfeiffer RM, Turesson I.
PMID: 31318385
JAMA Oncol. 2019 Sep 01;5(9):1293-1301. doi: 10.1001/jamaoncol.2019.1568.

IMPORTANCE: Multiple myeloma is consistently preceded by monoclonal gammopathy of undetermined significance (MGUS). Risk models that estimate the risk of progression from MGUS to multiple myeloma use data from a single time point, usually the initial workup.OBJECTIVE: To longitudinally...

Cite
Landgren O, Hofmann JN, McShane CM, et al. Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma. JAMA Oncol. 2019;5(9):1293-1301doi: 10.1001/jamaoncol.2019.1568.
Landgren, O., Hofmann, J. N., McShane, C. M., Santo, L., Hultcrantz, M., Korde, N., Mailankody, S., Kazandjian, D., Murata, K., Thoren, K., Ramanathan, L., Dogan, A., Rustad, E., Lu, S. X., Akhlaghi, T., Kristinsson, S. Y., Björkholm, M., Devlin, S., Purdue, M. P., Pfeiffer, R. M., & Turesson, I. (2019). Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma. JAMA oncology, 5(9), 1293-1301. https://doi.org/10.1001/jamaoncol.2019.1568
Landgren, Ola, et al. "Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma." JAMA oncology vol. 5,9 (2019): 1293-1301. doi: https://doi.org/10.1001/jamaoncol.2019.1568
Landgren O, Hofmann JN, McShane CM, Santo L, Hultcrantz M, Korde N, Mailankody S, Kazandjian D, Murata K, Thoren K, Ramanathan L, Dogan A, Rustad E, Lu SX, Akhlaghi T, Kristinsson SY, Björkholm M, Devlin S, Purdue MP, Pfeiffer RM, Turesson I. Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma. JAMA Oncol. 2019 Sep 01;5(9):1293-1301. doi: 10.1001/jamaoncol.2019.1568. PMID: 31318385; PMCID: PMC6646992.
Copy Download .nbib Format: NLM
Association of spinal instability due to metastatic disease with increased mortality and a proposed clinical pathway for treatment.

Journal of neurosurgery. Spine

Sullivan PZ, Albayar A, Ramayya AG, McShane B, Marcotte P, Malhotra NR, Ali ZS, Chen HI, Janjua MB, Saifi C, Schuster J, Grady MS, Jones J, Ozturk AK.
PMID: 32059185
J Neurosurg Spine. 2020 Feb 14;1-8. doi: 10.3171/2019.11.SPINE19775. Epub 2020 Feb 14.

OBJECTIVE: Multidisciplinary treatment including medical oncology, radiation oncology, and surgical consultation is necessary to provide comprehensive therapy for patients with spinal metastases. The goal of this study was to review the use of radiation therapy and/or surgical intervention and...

Cite
Sullivan PZ, Albayar A, Ramayya AG, et al. Association of spinal instability due to metastatic disease with increased mortality and a proposed clinical pathway for treatment. J Neurosurg Spine. 2020;1-8doi: 10.3171/2019.11.SPINE19775.
Sullivan, P. Z., Albayar, A., Ramayya, A. G., McShane, B., Marcotte, P., Malhotra, N. R., Ali, Z. S., Chen, H. I., Janjua, M. B., Saifi, C., Schuster, J., Grady, M. S., Jones, J., & Ozturk, A. K. (2020). Association of spinal instability due to metastatic disease with increased mortality and a proposed clinical pathway for treatment. Journal of neurosurgery. Spine, 1-8. https://doi.org/10.3171/2019.11.SPINE19775
Sullivan, Patricia Zadnik, et al. "Association of spinal instability due to metastatic disease with increased mortality and a proposed clinical pathway for treatment." Journal of neurosurgery. Spine vol. (2020): 1-8. doi: https://doi.org/10.3171/2019.11.SPINE19775
Sullivan PZ, Albayar A, Ramayya AG, McShane B, Marcotte P, Malhotra NR, Ali ZS, Chen HI, Janjua MB, Saifi C, Schuster J, Grady MS, Jones J, Ozturk AK. Association of spinal instability due to metastatic disease with increased mortality and a proposed clinical pathway for treatment. J Neurosurg Spine. 2020 Feb 14;1-8. doi: 10.3171/2019.11.SPINE19775. Epub 2020 Feb 14. PMID: 32059185.
Copy Download .nbib Format: NLM
Exploring patients' and carers' views about the clinical use of ketamine to inform policy and practical decisions: mixed-methods study.

BJPsych open

Jilka S, Murray C, Wieczorek A, Griffiths H, Wykes T, McShane R.
PMID: 31530293
BJPsych Open. 2019 Jul 30;5(5):e62. doi: 10.1192/bjo.2019.52.

BACKGROUND: Only one-third of patients with major depressive disorder achieve remission. One new and promising treatment, ketamine, may prove challenging to implement because of its abuse potential. Although clinicians' views have been sought, we need patients' views before large...

Cite
Jilka S, Murray C, Wieczorek A, et al. Exploring patients' and carers' views about the clinical use of ketamine to inform policy and practical decisions: mixed-methods study. BJPsych Open. 2019;5(5):e62doi: 10.1192/bjo.2019.52.
Jilka, S., Murray, C., Wieczorek, A., Griffiths, H., Wykes, T., & McShane, R. (2019). Exploring patients' and carers' views about the clinical use of ketamine to inform policy and practical decisions: mixed-methods study. BJPsych open, 5(5), e62. https://doi.org/10.1192/bjo.2019.52
Jilka, Sagar, et al. "Exploring patients' and carers' views about the clinical use of ketamine to inform policy and practical decisions: mixed-methods study." BJPsych open vol. 5,5 (2019): e62. doi: https://doi.org/10.1192/bjo.2019.52
Jilka S, Murray C, Wieczorek A, Griffiths H, Wykes T, McShane R. Exploring patients' and carers' views about the clinical use of ketamine to inform policy and practical decisions: mixed-methods study. BJPsych Open. 2019 Jul 30;5(5):e62. doi: 10.1192/bjo.2019.52. PMID: 31530293; PMCID: PMC6669880.
Copy Download .nbib Format: NLM
Mucus.

Current biology : CB

McShane A, Bath J, Jaramillo AM, Ridley C, Walsh AA, Evans CM, Thornton DJ, Ribbeck K.
PMID: 34375594
Curr Biol. 2021 Aug 09;31(15):R938-R945. doi: 10.1016/j.cub.2021.06.093.

Mucus is a slimy hydrogel that lines the mucosal surfaces in our body, including the intestines, stomach, eyes, lungs and urogenital tract. This glycoprotein-rich network is truly the jack of all trades. As a barrier, it lubricates surfaces, protects...

Cite
McShane A, Bath J, Jaramillo AM, et al. Mucus. Curr Biol. 2021;31(15):R938-R945doi: 10.1016/j.cub.2021.06.093.
McShane, A., Bath, J., Jaramillo, A. M., Ridley, C., Walsh, A. A., Evans, C. M., Thornton, D. J., & Ribbeck, K. (2021). Mucus. Current biology : CB, 31(15), R938-R945. https://doi.org/10.1016/j.cub.2021.06.093
McShane, Abigail, et al. "Mucus." Current biology : CB vol. 31,15 (2021): R938-R945. doi: https://doi.org/10.1016/j.cub.2021.06.093
McShane A, Bath J, Jaramillo AM, Ridley C, Walsh AA, Evans CM, Thornton DJ, Ribbeck K. Mucus. Curr Biol. 2021 Aug 09;31(15):R938-R945. doi: 10.1016/j.cub.2021.06.093. PMID: 34375594; PMCID: PMC8759706.
Copy Download .nbib Format: NLM
Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study.

Technical innovations & patient support in radiation oncology

Wu AK, Damico NJ, Healy E, Kharouta MZ, Khandel G, Deshane A, Sipos J, Eckstein J, Zoller W, Ewing A, Ling S, Wobb J, Mitchell D, Grecula J, Jhawar S, Miller E, Gamez M, Diavolitsis V, Blakaj D, Bhatt AD.
PMID: 34765751
Tech Innov Patient Support Radiat Oncol. 2021 Nov 01;20:28-34. doi: 10.1016/j.tipsro.2021.10.003. eCollection 2021 Dec.

BACKGROUND: Radiation-induced hypothyroidism is a common toxicity of head and neck radiation. Our re-planning study aimed to reduce thyroid dose while maintaining target coverage with IMRT.METHODS: We retrospectively identified patients with oral-cavity (n = 5) and oropharyngeal cancer (n...

Cite
Wu AK, Damico NJ, Healy E, et al. Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study. Tech Innov Patient Support Radiat Oncol. 2021;20:28-34doi: 10.1016/j.tipsro.2021.10.003.
Wu, A. K., Damico, N. J., Healy, E., Kharouta, M. Z., Khandel, G., Deshane, A., Sipos, J., Eckstein, J., Zoller, W., Ewing, A., Ling, S., Wobb, J., Mitchell, D., Grecula, J., Jhawar, S., Miller, E., Gamez, M., Diavolitsis, V., Blakaj, D., & Bhatt, A. D. (2021). Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study. Technical innovations & patient support in radiation oncology, 2028-34. https://doi.org/10.1016/j.tipsro.2021.10.003
Wu, Anna K, et al. "Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study." Technical innovations & patient support in radiation oncology vol. 20 (2021): 28-34. doi: https://doi.org/10.1016/j.tipsro.2021.10.003
Wu AK, Damico NJ, Healy E, Kharouta MZ, Khandel G, Deshane A, Sipos J, Eckstein J, Zoller W, Ewing A, Ling S, Wobb J, Mitchell D, Grecula J, Jhawar S, Miller E, Gamez M, Diavolitsis V, Blakaj D, Bhatt AD. Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study. Tech Innov Patient Support Radiat Oncol. 2021 Nov 01;20:28-34. doi: 10.1016/j.tipsro.2021.10.003. eCollection 2021 Dec. PMID: 34765751; PMCID: PMC8571516.
Copy Download .nbib Format: NLM
Human-Computer Agreement of Electrocardiogram Interpretation for Patients Referred to and Declined for Primary Percutaneous Coronary Intervention: Retrospective Data Analysis Study.

JMIR medical informatics

Iftikhar A, Bond R, Mcgilligan V, Leslie SJ, Knoery C, Shand J, Ramsewak A, Sharma D, McShane A, Rjoob K, Peace A.
PMID: 33650984
JMIR Med Inform. 2021 Mar 02;9(3):e24188. doi: 10.2196/24188.

BACKGROUND: When a patient is suspected of having an acute myocardial infarction, they are accepted or declined for primary percutaneous coronary intervention partly based on clinical assessment of their 12-lead electrocardiogram (ECG) and ST-elevation myocardial infarction criteria.OBJECTIVE: We retrospectively...

Cite
Iftikhar A, Bond R, Mcgilligan V, et al. Human-Computer Agreement of Electrocardiogram Interpretation for Patients Referred to and Declined for Primary Percutaneous Coronary Intervention: Retrospective Data Analysis Study. JMIR Med Inform. 2021;9(3):e24188doi: 10.2196/24188.
Iftikhar, A., Bond, R., Mcgilligan, V., Leslie, S. J., Knoery, C., Shand, J., Ramsewak, A., Sharma, D., McShane, A., Rjoob, K., & Peace, A. (2021). Human-Computer Agreement of Electrocardiogram Interpretation for Patients Referred to and Declined for Primary Percutaneous Coronary Intervention: Retrospective Data Analysis Study. JMIR medical informatics, 9(3), e24188. https://doi.org/10.2196/24188
Iftikhar, Aleeha, et al. "Human-Computer Agreement of Electrocardiogram Interpretation for Patients Referred to and Declined for Primary Percutaneous Coronary Intervention: Retrospective Data Analysis Study." JMIR medical informatics vol. 9,3 (2021): e24188. doi: https://doi.org/10.2196/24188
Iftikhar A, Bond R, Mcgilligan V, Leslie SJ, Knoery C, Shand J, Ramsewak A, Sharma D, McShane A, Rjoob K, Peace A. Human-Computer Agreement of Electrocardiogram Interpretation for Patients Referred to and Declined for Primary Percutaneous Coronary Intervention: Retrospective Data Analysis Study. JMIR Med Inform. 2021 Mar 02;9(3):e24188. doi: 10.2196/24188. PMID: 33650984; PMCID: PMC7967222.
Copy Download .nbib Format: NLM
A large National Institute for Health Research (NIHR) Biomedical Research Centre facilitates impactful cross-disciplinary and collaborative translational research publications and research collaboration networks: a bibliometric evaluation study.

Journal of translational medicine

Kiparoglou V, Brown LA, McShane H, Channon KM, Shah SGS.
PMID: 34838033
J Transl Med. 2021 Nov 27;19(1):483. doi: 10.1186/s12967-021-03149-x.

BACKGROUND: The evaluation of translational health research is important for various reasons such as the research impact assessment, research funding allocation, accountability, and strategic research policy formulation. The purpose of this study was to evaluate the research productivity, strength...

Cite
Kiparoglou V, Brown LA, McShane H, et al. A large National Institute for Health Research (NIHR) Biomedical Research Centre facilitates impactful cross-disciplinary and collaborative translational research publications and research collaboration networks: a bibliometric evaluation study. J Transl Med. 2021;19(1):483doi: 10.1186/s12967-021-03149-x.
Kiparoglou, V., Brown, L. A., McShane, H., Channon, K. M., & Shah, S. G. S. (2021). A large National Institute for Health Research (NIHR) Biomedical Research Centre facilitates impactful cross-disciplinary and collaborative translational research publications and research collaboration networks: a bibliometric evaluation study. Journal of translational medicine, 19(1), 483. https://doi.org/10.1186/s12967-021-03149-x
Kiparoglou, Vasiliki, et al. "A large National Institute for Health Research (NIHR) Biomedical Research Centre facilitates impactful cross-disciplinary and collaborative translational research publications and research collaboration networks: a bibliometric evaluation study." Journal of translational medicine vol. 19,1 (2021): 483. doi: https://doi.org/10.1186/s12967-021-03149-x
Kiparoglou V, Brown LA, McShane H, Channon KM, Shah SGS. A large National Institute for Health Research (NIHR) Biomedical Research Centre facilitates impactful cross-disciplinary and collaborative translational research publications and research collaboration networks: a bibliometric evaluation study. J Transl Med. 2021 Nov 27;19(1):483. doi: 10.1186/s12967-021-03149-x. PMID: 34838033; PMCID: PMC8626935.
Copy Download .nbib Format: NLM
Telephone Triage Toolkit for Children's cancer services: A quality initiative.

European journal of oncology nursing : the official journal of European Oncology Nursing Society

Hawkins J, Jones P, McShane B, Morris H, Ollett L, Sanderson L.
PMID: 34837802
Eur J Oncol Nurs. 2021 Sep 14;56:102036. doi: 10.1016/j.ejon.2021.102036. Epub 2021 Sep 14.

PURPOSE: Service development to improve patient safety and experience, and improve staff safety and confidence when managing telephone calls from parents or carers of children with cancer in the UK.METHOD: A multi-layered mixed methods approach broadly based on sequential...

Cite
Hawkins J, Jones P, McShane B, et al. Telephone Triage Toolkit for Children's cancer services: A quality initiative. Eur J Oncol Nurs. 2021;56:102036doi: 10.1016/j.ejon.2021.102036.
Hawkins, J., Jones, P., McShane, B., Morris, H., Ollett, L., & Sanderson, L. (2021). Telephone Triage Toolkit for Children's cancer services: A quality initiative. European journal of oncology nursing : the official journal of European Oncology Nursing Society, 56102036. https://doi.org/10.1016/j.ejon.2021.102036
Hawkins, Jeanette, et al. "Telephone Triage Toolkit for Children's cancer services: A quality initiative." European journal of oncology nursing : the official journal of European Oncology Nursing Society vol. 56 (2021): 102036. doi: https://doi.org/10.1016/j.ejon.2021.102036
Hawkins J, Jones P, McShane B, Morris H, Ollett L, Sanderson L. Telephone Triage Toolkit for Children's cancer services: A quality initiative. Eur J Oncol Nurs. 2021 Sep 14;56:102036. doi: 10.1016/j.ejon.2021.102036. Epub 2021 Sep 14. PMID: 34837802.
Copy Download .nbib Format: NLM
Current Perspectives on the Systemic Management of Atopic Dermatitis.

Journal of asthma and allergy

Davari DR, Nieman EL, McShane DB, Morrell DS.
PMID: 34103945
J Asthma Allergy. 2021 Jun 01;14:595-607. doi: 10.2147/JAA.S287638. eCollection 2021.

Atopic dermatitis (AD) is a common disease of childhood, and some patients experience a prolonged clinical course into adolescence and adulthood. Systemic management is required when AD is not adequately controlled with topical medications. Our aim is to provide...

Cite
Davari DR, Nieman EL, McShane DB, et al. Current Perspectives on the Systemic Management of Atopic Dermatitis. J Asthma Allergy. 2021;14:595-607doi: 10.2147/JAA.S287638.
Davari, D. R., Nieman, E. L., McShane, D. B., & Morrell, D. S. (2021). Current Perspectives on the Systemic Management of Atopic Dermatitis. Journal of asthma and allergy, 14595-607. https://doi.org/10.2147/JAA.S287638
Davari, Danielle R, et al. "Current Perspectives on the Systemic Management of Atopic Dermatitis." Journal of asthma and allergy vol. 14 (2021): 595-607. doi: https://doi.org/10.2147/JAA.S287638
Davari DR, Nieman EL, McShane DB, Morrell DS. Current Perspectives on the Systemic Management of Atopic Dermatitis. J Asthma Allergy. 2021 Jun 01;14:595-607. doi: 10.2147/JAA.S287638. eCollection 2021. PMID: 34103945; PMCID: PMC8179820.
Copy Download .nbib Format: NLM
Fine-grained, spatiotemporal datasets measuring 200 years of land development in the United States.

Earth system science data

Uhl JH, Leyk S, McShane CM, Braswell AE, Connor DS, Balk D.
PMID: 34970355
Earth Syst Sci Data. 2021;13(1):119-153. doi: 10.5194/essd-13-119-2021. Epub 2021 Jan 27.

The collection, processing, and analysis of remote sensing data since the early 1970s has rapidly improved our understanding of change on the Earth's surface. While satellite-based Earth observation has proven to be of vast scientific value, these data are...

Cite
Uhl JH, Leyk S, McShane CM, et al. Fine-grained, spatiotemporal datasets measuring 200 years of land development in the United States. Earth Syst Sci Data. 2021;13(1):119-153doi: 10.5194/essd-13-119-2021.
Uhl, J. H., Leyk, S., McShane, C. M., Braswell, A. E., Connor, D. S., & Balk, D. (2021). Fine-grained, spatiotemporal datasets measuring 200 years of land development in the United States. Earth system science data, 13(1), 119-153. https://doi.org/10.5194/essd-13-119-2021
Uhl, Johannes H, et al. "Fine-grained, spatiotemporal datasets measuring 200 years of land development in the United States." Earth system science data vol. 13,1 (2021): 119-153. doi: https://doi.org/10.5194/essd-13-119-2021
Uhl JH, Leyk S, McShane CM, Braswell AE, Connor DS, Balk D. Fine-grained, spatiotemporal datasets measuring 200 years of land development in the United States. Earth Syst Sci Data. 2021;13(1):119-153. doi: 10.5194/essd-13-119-2021. Epub 2021 Jan 27. PMID: 34970355; PMCID: PMC8716019.
Copy Download .nbib Format: NLM
Ketamine treatment for individuals with treatment-resistant depression: longitudinal qualitative interview study of patient experiences.

BJPsych open

Lascelles K, Marzano L, Brand F, Trueman H, McShane R, Hawton K.
PMID: 33283696
BJPsych Open. 2020 Dec 07;7(1):e9. doi: 10.1192/bjo.2020.132.

BACKGROUND: Ketamine has recently received considerable attention regarding its antidepressant and anti-suicidal effects. Trials have generally focused on short-term effects of single intravenous infusions. Research on patient experiences is lacking.AIMS: To investigate the experiences over time of individuals receiving...

Cite
Lascelles K, Marzano L, Brand F, et al. Ketamine treatment for individuals with treatment-resistant depression: longitudinal qualitative interview study of patient experiences. BJPsych Open. 2020;7(1):e9doi: 10.1192/bjo.2020.132.
Lascelles, K., Marzano, L., Brand, F., Trueman, H., McShane, R., & Hawton, K. (2020). Ketamine treatment for individuals with treatment-resistant depression: longitudinal qualitative interview study of patient experiences. BJPsych open, 7(1), e9. https://doi.org/10.1192/bjo.2020.132
Lascelles, Karen, et al. "Ketamine treatment for individuals with treatment-resistant depression: longitudinal qualitative interview study of patient experiences." BJPsych open vol. 7,1 (2020): e9. doi: https://doi.org/10.1192/bjo.2020.132
Lascelles K, Marzano L, Brand F, Trueman H, McShane R, Hawton K. Ketamine treatment for individuals with treatment-resistant depression: longitudinal qualitative interview study of patient experiences. BJPsych Open. 2020 Dec 07;7(1):e9. doi: 10.1192/bjo.2020.132. PMID: 33283696; PMCID: PMC7791565.
Copy Download .nbib Format: NLM
Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial.

JAMA oncology

Kalinsky K, Hong F, McCourt CK, Sachdev JC, Mitchell EP, Zwiebel JA, Doyle LA, McShane LM, Li S, Gray RJ, Rubinstein LV, Patton D, Williams PM, Hamilton SR, Conley BA, O'Dwyer PJ, Harris LN, Arteaga CL, Chen AP, Flaherty KT.
PMID: 33377972
JAMA Oncol. 2021 Feb 01;7(2):271-278. doi: 10.1001/jamaoncol.2020.6741.

IMPORTANCE: In the National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH) trial, agents targeting genetic tumor abnormalities are administered to patients. In the NCI-MATCH subprotocol EAY131-Y trial, patients with an AKT1 E17K-mutated metastatic tumor received the pan-AKT inhibitor...

Cite
Kalinsky K, Hong F, McCourt CK, et al. Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial. JAMA Oncol. 2021;7(2):271-278doi: 10.1001/jamaoncol.2020.6741.
Kalinsky, K., Hong, F., McCourt, C. K., Sachdev, J. C., Mitchell, E. P., Zwiebel, J. A., Doyle, L. A., McShane, L. M., Li, S., Gray, R. J., Rubinstein, L. V., Patton, D., Williams, P. M., Hamilton, S. R., Conley, B. A., O'Dwyer, P. J., Harris, L. N., Arteaga, C. L., Chen, A. P., & Flaherty, K. T. (2021). Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial. JAMA oncology, 7(2), 271-278. https://doi.org/10.1001/jamaoncol.2020.6741
Kalinsky, Kevin, et al. "Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial." JAMA oncology vol. 7,2 (2021): 271-278. doi: https://doi.org/10.1001/jamaoncol.2020.6741
Kalinsky K, Hong F, McCourt CK, Sachdev JC, Mitchell EP, Zwiebel JA, Doyle LA, McShane LM, Li S, Gray RJ, Rubinstein LV, Patton D, Williams PM, Hamilton SR, Conley BA, O'Dwyer PJ, Harris LN, Arteaga CL, Chen AP, Flaherty KT. Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial. JAMA Oncol. 2021 Feb 01;7(2):271-278. doi: 10.1001/jamaoncol.2020.6741. PMID: 33377972; PMCID: PMC7774047.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 196 entries